Isolation and identification of Paenibacillus sp. FM-6, involved in the biotransformation of albendazole

No abstract is available for this paper.

• Publication year

  2014

• Venue

  World Journal of Microbiology & Biotechnology

• Publication date

  2014-07-09

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s11274-014-1698-9PMID 25005007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paenibacillus polymyxa Rhizobacteria and Their Synthesized Exoglycans in Interaction with Wheat Roots: Colonization and Root Hair Deformation

  2013cited by this paper
• Lipopeptide biosurfactants from Paenibacillus polymyxa inhibit single and mixed species biofilms

  2012cited by this paper
• Paenibacillus polymyxa PKB1 produces variants of polymyxin B-type antibiotics.

  2011cited by this paper
• Potential of Thermophilic Fungus Rhizomucor pusillus NRRL 28626 in Biotransformation of Antihelmintic Drug Albendazole

  2011cited by this paper
• Determination of albendazole sulfoxide,albendazole sulfone and albendazole aminosulfone in freshwater fish products

  2011cited by this paper
• Simultaneous determination of albendazole and its metabolites in fish muscle tissue by stable isotope dilution ultra-performance liquid chromatography tandem mass spectrometry

  2011cited by this paper
• Ecology and biotechnological potential of Paenibacillus polymyxa: a minireview

  2009cited by this paper
• The realm of penicillin G acylase in β-lactam antibiotics

  2008cited by this paper
• Biotransformation of albendazole by fungi

  2008cited by this paper
• Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysis.

  2008cited by this paper
• MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

  2007influential reference
• Paenibacillus sp. Strain JDR-2 and XynA1: a Novel System for Methylglucuronoxylan Utilization

  2006cited by this paper
• Molecular identification of rRNA group 3 bacilli (Ash, Farrow, Wallbanks and Collins) using a PCR probe test

  2004cited by this paper
• Paenibacillus antarcticus sp. nov., a novel psychrotolerant organism from the Antarctic environment.

  2004cited by this paper
• Pharmacokinetics of albendazole in man

  2004cited by this paper
• Ecology of Bacillus and Paenibacillus spp. in Agricultural Systems.

  2004cited by this paper
• Pharmacological characteristics of parenteral IGF-I administration.

  2003cited by this paper
• Application of microbial biotransformation for the new drug discovery using natural drugs as substrates.

  2003cited by this paper
• A record total of 41 new therapeutic agents reached the US. 1narket for the first time in 1996.

  1997cited by this paper
• New drugs of 1996.

  1997cited by this paper
• Nucleic acid techniques in bacterial systematics

  1991cited by this paper
• 16S/23S rRNA sequencing

  1991cited by this paper
• Bergey's Manual of Determinative Bacteriology.

  1975cited by this paper
• Bergey's Manual of Determinative Bacteriology

  1948cited by this paper
• Bergey's Manual of Determinative Bacteriology (5th ed.)

  1939cited by this paper

• The song remains the same. The lab bench dilemma of using shaken flasks in microbial biotransformation experiments

  2023cites this paper
• Biodegradation of anthelmintics in soils: does prior exposure of soils to anthelmintics accelerate their dissipation?

  2022cites this paper
• Pharmacokinetics and tissue distribution study of liposomal albendazole in naturally Echinococcus granulosus infected sheep by a validated UPLC-Q-TOF-MS method.

  2020cites this paper
• Environmental risk assessment of the anthelmintic albendazole in Eastern Africa, based on a systematic review.

  2020cites this paper